Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy in the Management of Breast Cancer-Prospective Study

NCT04037852 · Changhua Christian Hospital · Updated 13 Sept 2021

What is being tested
robotic assisted nipple sparing mastectomy; Endoscopic assisted nipple sparing mastectomy; Conventional nipple sparing mastectomy
For
Breast Cancer Female
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 20 years to 70 years. About 180 people. The full rules are on the registry page.
Where
Taiwan (11 sites)
When
Starts or started 1 Oct 2019, ends 28 Feb 2022. Registered 30 July 2019.
Results
None posted yet.

In the researchers' words

This study will prospectively evaluate the surgical outcomes of robotic nipple sparing mastectomy (NSM) compared with endoscopic assisted NSM or conventional NSM in the management of breast cancer. One-third patients would received R-NSM, another one-third received C-NSM while the other one-third would receive E-NSM.
ClinicalTrials.gov, NCT04037852

Sites

  • Changhua Christian HospitalChanghua, Taiwan
  • Kaohsiung Medical University Hospital, Kaohsiung, TaiwanKaohsiung City, Taiwan
  • China Medical University Hospital, Taichung, TaiwanTaichung, Taiwan
  • National Cheng Kung University HospitalTainan, Taiwan
  • National Taiwan University HospitalTaipei, Taiwan
  • Shin Kong Wu Ho-Su Memorial HospitalTaipei, Taiwan
  • Shuang-Ho Hospital - Taipei Medical UniversityTaipei, Taiwan
  • Taipei Municipal Wan Fang Hospital, TawianTaipei, Taiwan
  • Taipei Veterans General HospitalTaipei, Taiwan
  • Tri-Service General HospitalTaipei, Taiwan
  • Chang Gung Memorial Hospital, Taoyuan, TaiwanTaoyuan, Taiwan